Topics

6/9/16

Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition, has received a $7 million grant to develop an effective way to treat drug users with the hepatitis C virus (HCV).

5/2/16

Jun-Xu Li, MD, PhD, assistant professor of pharmacology and toxicology, has received the Joseph Cochin Young Investigator Award from the College of Problems of Drug Dependence (CPDD) for his research on pharmacotherapy for stimulant abuse.

4/6/16

According to a fact sheet released by the White House, the Jacobs School of Medicine and Biomedical Sciences is among medical schools nationwide at the forefront of fighting the opioid epidemic.

8/27/15

Researchers in the lab of David Dietz, PhD, assistant professor of pharmacology and toxicology, discovered an unknown neural pathway that can regulate changes made in the brain from cocaine use. 

9/19/14

Research by David Dietz, PhD, has the potential to identify novel therapies to treat addiction to cocaine and other psychostimulants, for which no effective drug therapy exists.

7/11/14

Research co-authored by Andrew H. Talal, MD, shows that injection drug users who are enrolled in a treatment program want to be educated about hepatitis C virus (HCV) and are willing to be treated.

3/7/14

The risks of the new painkiller Zohydro — an extended-release formulation of hydrocodone — far outweigh the benefits and could lead to more overdoses, according to Richard D. Blondell, MD, vice chair for addiction medicine and professor of family medicine.

10/9/13

Richard D. Blondell, MD, vice chair for addiction medicine and professor of family medicine, will direct a new national center aimed at training physicians to address addiction through early intervention and prevention.

11/3/11

With a major grant, family medicine physicians at UB are forming a council that will develop curricula and national standards of excellence for postgraduate medical education programs in addiction medicine.

5/31/11

UB’s addiction medicine residency is one of the first of its kind to be accredited by the American Board of Addiction Medicine Foundation.